Forte Biosciences Inc (NYSE: FBRX) — Healthcare · Share Price, Chart & Market Data
About: Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $27.10 (-1.27%)
FBRXForte Biosciences Inc
Loading watchlist status…
Trade FBRX now
Forte Biosciences Inc share price
FBRX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 5:48 pm GMT+0
FBRX price performance
-17.479%
5D
6.275%
1M
14.782%
YTD
280.618%
1Y
FBRX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 5:48 pm GMT+0
FBRX details
FBRX Market Signals